These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 11743639

  • 1. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
    Wu F, Nishioka M, Fujita J, Murota M, Ohtsuki Y, Ishida T, Kuriyama S.
    Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
    [Abstract] [Full Text] [Related]

  • 2. CYFRA 21-1 is released in TNF-alpha-induced apoptosis in the hepatocellular carcinoma cell line HuH-7.
    Wu F, Fujita J, Murota M, Li JQ, Ishida T, Nishioka M, Imaida Y, Kuriyama S.
    Int J Oncol; 2002 Aug; 21(2):441-5. PubMed ID: 12118343
    [Abstract] [Full Text] [Related]

  • 3. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
    Liu B, Hervé J, Bioulac-Sage P, Valogne Y, Roux J, Yilmaz F, Boisgard R, Guettier C, Calès P, Tavitian B, Samuel D, Clerc J, Bréchot C, Faivre J.
    Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
    [Abstract] [Full Text] [Related]

  • 4. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY.
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
    Batmunkh E, Tátrai P, Szabó E, Lódi C, Holczbauer A, Páska C, Kupcsulik P, Kiss A, Schaff Z, Kovalszky I.
    Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
    [Abstract] [Full Text] [Related]

  • 6. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
    Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y.
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines.
    Dohmoto K, Hojo S, Fujita J, Ueda Y, Bandoh S, Yamaji Y, Ohtsuki Y, Dobashi N, Takahara J.
    Lung Cancer; 2000 Oct; 30(1):55-63. PubMed ID: 11008010
    [Abstract] [Full Text] [Related]

  • 8. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ.
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [Abstract] [Full Text] [Related]

  • 9. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
    He F, Yan Q, Fan L, Liu Y, Cui J, Wang J, Wang L, Wang Y, Wang Z, Guo Y, Huang G.
    Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
    [Abstract] [Full Text] [Related]

  • 10. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [Abstract] [Full Text] [Related]

  • 11. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines.
    Dohmoto K, Hojo S, Fujita J, Yang Y, Ueda Y, Bandoh S, Yamaji Y, Ohtsuki Y, Dobashi N, Ishida T, Takahara J.
    Int J Cancer; 2001 Feb 15; 91(4):468-73. PubMed ID: 11251967
    [Abstract] [Full Text] [Related]

  • 12. Expression of CD44 in human hepatocellular carcinoma cell lines.
    Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M.
    Hepatology; 1995 May 15; 21(5):1276-84. PubMed ID: 7537711
    [Abstract] [Full Text] [Related]

  • 13. Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma.
    Chen Z, Shao JB, Wu W.
    Hepatobiliary Pancreat Dis Int; 2002 Nov 15; 1(4):570-3. PubMed ID: 14607688
    [Abstract] [Full Text] [Related]

  • 14. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS, Ramalho LN, Della Porta L, Zucoloto S.
    J Gastroenterol Hepatol; 2006 Aug 15; 21(8):1276-80. PubMed ID: 16872309
    [Abstract] [Full Text] [Related]

  • 15. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR, Xu Y, Shi GM, Fan J, Zhou J, Ji Y, Sun HC, Qiu SJ, Yu B, Gao Q, He YZ, Qin WZ, Chen RX, Yang GH, Wu B, Lu Q, Wu ZQ, Tang ZY.
    Clin Cancer Res; 2008 Jun 15; 14(12):3850-9. PubMed ID: 18559605
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.